(Q45259300)

11 December 2017

0 references

Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis (English)

1 reference

11 December 2017

1 reference

Xiao-Wei Yu

1

1 reference

11 December 2017

Tian-Yi Wu

2

1 reference

11 December 2017

Xiang Yi

3

1 reference

11 December 2017

Wei-Ping Ren

4

1 reference

11 December 2017

Zu-bin Zhou

5

1 reference

11 December 2017

Yu-qiang Sun

6

1 reference

11 December 2017

Chang-qing Zhang

7

1 reference

11 December 2017

publication date

2 August 2013

1 reference

11 December 2017

1 reference

11 December 2017

volume

35

1 reference

11 December 2017

issue

1

1 reference

11 December 2017

page(s)

155-160

1 reference

Osteosarcoma: the COSS experience

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

VEGF and the quest for tumour angiogenesis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

Systematic reviews of evaluations of prognostic variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

Correlation between clinical outcome and growth factor pathway expression in osteogenic sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

The level of vascular endothelial growth factor as a predictor of a poor prognosis in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

VEGF and EMMPRIN expression correlates with survival of patients with osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

The vascular endothelial growth factor family and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

Constitutive and inducible expression and regulation of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

Vascular endothelial growth factor signaling pathways: therapeutic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-1019-1

Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis

21 January 2018

1 reference

12 December 2020

Risk of venous thromboembolism with the erythropoiesis-stimulating agents (ESAs) for the treatment of cancer-associated anemia: a meta-analysis of randomized control trials

1 reference

12 December 2020

Prognostic factors in osteosarcoma: a critical review.

1 reference

12 December 2020

CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis

1 reference

12 December 2020

Expression and significance of TGF-beta isoform and VEGF in osteosarcoma

1 reference

12 December 2020

Prognostic significance of vascular endothelial growth factor expression in hepatocellular carcinoma tissue: a meta-analysis

1 reference

12 December 2020

Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: a meta-analysis

1 reference

12 December 2020

Prognostic value of COX-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis

1 reference

12 December 2020

Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma

1 reference

12 December 2020

[Expression of hypoxia-inducible factor 1α in osteosarcoma and its value in predicting chemosensitivity]

1 reference

12 December 2020

Neuropilin-2 expression affects the increased vascularization and is a prognostic factor in osteosarcoma

1 reference

12 December 2020

Does the degree of intratumoural microvessel density and VEGF expression have prognostic significance in osteosarcoma?

1 reference

12 December 2020

A prognostic evaluation of vascular endothelial growth factor in children and young adults with osteosarcoma

1 reference

12 December 2020

Vascular endothelial growth factor expression in osteosarcoma

1 reference

12 December 2020

Expression of molecular markers in the tumor and survival prognosis in osteosarcoma

1 reference

12 December 2020

Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature

1 reference

12 December 2020

10.1007/S13277-013-1019-1

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

1049632467

0 references

1 reference